Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Airline employees at Arturo Merino Benitez International Airport in Santiago on Monday, after Chile resumed international flights. Photo: Martin Bernetti/AFP via Getty Images

The International Air Transport Association (IATA) announced Monday that it's "in the final development phase" of a "digital passport" mobile app that would receive COVID-19 test and vaccination certificates.

Why it matters: Per a statement from Nick Careen, IATA's senior vice president of airport, passenger, cargo and security, the app would "get people traveling again safely," as the airline industry seeks to recover from the pandemic.

  • "In the immediate term, that means giving governments confidence that systematic COVID-19 testing can work as a replacement for quarantine requirements," Careen said. "And that will eventually develop into a vaccine program."

Driving the news: IATA's announcement comes after three coronavirus vaccine candidates Pfizer-BioNTech, Moderna and the University of Oxford-AstraZeneca, this month reported efficacy rates of 90% or more.

For the record: Qantas CEO Alan Joyce has publicly thrown his support behind "COVID passports," telling Channel 9 on Monday that Australia's national carrier planned to require travelers to provide proof of having a coronavirus vaccination as a non-negotiable condition of international air travel.

  • Joyce said he'd spoken with other airlines, adding: "It's going to be a common theme across the board." For now, only Qantas has made such an announcement.

The big picture: IATA and British Airways' parent company, International Airlines Group (IAG), have been working together on the digital pass and plan to conduct a trial later this year, with the launch "slated for quarter one 2021," IATA said.

  • Alan Murray Hayden, IATA's head of passenger and security products, said at a briefing the app would use blockchain technology, but it wouldn't store data, per Bloomberg.
  • Other similar apps have already been tested. Trials of the World Economic Forum and non-profit Commons Project Foundation's CommonPass app were conducted on New York-London flights and International SOS's AOKpass is being used between Abu Dhabi and Pakistan, Bloomberg notes.

By the numbers: The U.S. surpassed 12 million confirmed coronavirus cases last Saturday and 250,000 deaths from COVID-19 last Wednesday.

  • The virus death toll in the U.S. had exceeded 257,700 by Tuesday morning. Over 12.4 million Americans have now tested positive for the virus, per Johns Hopkins.
  • Globally, almost 1.4 million people have lost their lives to the virus and more than 59.1 million have tested positive.

Go deeper: Designing digital immunity certificates for COVID-19

Go deeper

Jan 29, 2021 - Health

J&J says its one-shot vaccine is 66% effective against moderate to severe COVID

Photo: Thiago Prudêncio/SOPA Images/LightRocket via Getty Images

Johnson & Johnson announced Friday that its single-shot coronavirus vaccine was 66% effective in protecting against moderate to severe COVID-19 disease in Phase 3 trials, which was comprised of nearly 44,000 participants across eight countries.

Between the lines: The vaccine was 72% effective in the U.S., but only 57% effective in South Africa, where a more contagious variant has been spreading. It prevented 85% of severe infections and 100% of hospitalizations and deaths, according to the company.

Jan 29, 2021 - Health

Ex-CDC director Tom Frieden on the next COVID-19 vaccines

Americans fortunate enough to receive COVID vaccines now, outside of clinical trials, are getting shots made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way, with J&J's requiring a single dose.

Axios Re:Cap digs into the news and why it matters with Tom Frieden, former head of the CDC, as COVID-19 variants spread globally.